India, Oct. 30 -- Lupin Digital Health, India's leading cardiac digital-therapeutics company, has launched VITALYFE™, an AI-driven cardiometabolic wellness platform aimed at helping working professionals improve their heart health.
Built on LYFE, India's first CDSCO-approved Class C software medical device for cardiac conditions, VITALYFE™ extends hospital-grade cardiac care into the preventive wellness space.
Addressing India's growing cardiometabolic crisis, Lupin noted that up to 80% of corporate employees show early signs of hypertension and dyslipidemia — key risk factors for heart disease. The platform uses AI, behavioral science, and computer vision to detect early risks and deliver personalized, non-medical inter...